Northwire Canada EditionSunday, July 12, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings

Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results

By The Northwire Desk — AI Analysis Dec 04, 2025 · 07:00 COV · 1.95 Covalon Technologies Ltd.
COV · Price

Executive Summary

  • Covalon Technologies Ltd. will release its Q4 and full‑year Fiscal 2025 financial results on Thursday, December 11, 2025, before market open.
  • A conference call and webcast to discuss the results will be held at 8:30 am ET on the same day, with a live Q&A session for investors and analysts.
  • Recordings and copies of the financial statements and MD&A will be made available on Covalon’s website and SEDAR PLUS after the call.

Key Details

  • Release Timing: Thursday, December 11, 2025, pre‑market (exact time not specified).
  • Conference Call/Webcast: 8:30 am ET, Thursday, Dec 11, 2025.
  • Webcast link: https://events.q4inc.com/attendee/516259946
  • Toll‑free dial‑in: 1‑800‑549‑8228 (Toronto: 289‑819‑1520; New York: 646‑564‑2877) – Conference ID 57487.
  • Q&A Access: Participants may ask questions live on the call or via the webcast chat function.
  • Recording Availability: The call recording will be posted on Covalon’s website under “News & Events” → Investors tab.
  • Financial Documents: Full financial statements and MD&A will be accessible through SEDAR PLUS () and the “SEDAR Filings” section of Covalon’s Investor page.
  • Contact for Media/Investors: Brent Ashton, CEO – [email protected]; phone 1‑877‑711‑6055.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Covalon Technologies Ltd.

May 21, 2026 · 07:00

Covalon doubles down on infection prevention as CovaClear U.S. sales soar sixfold; zero-debt balance sheet and surging margins fuel re-rating.

Earnings Apr 15, 2026 · 17:30

Covalon Stabilizes Post-Dividend with Operational Momentum Despite Revenue Contraction

Production / Operations Feb 25, 2026 · 07:08

SEDAR Interim Financial Statements

None Feb 25, 2026 · 07:00

Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights

Earnings Feb 19, 2026 · 07:00

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

Earnings Dec 11, 2025 · 07:00

Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth

Earnings